No abstract available
Keywords:
COVID-19; Checkpoint inhibitors; Pneumonitis.
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
B7-H1 Antigen / antagonists & inhibitors
-
Betacoronavirus
-
COVID-19
-
CTLA-4 Antigen / antagonists & inhibitors
-
Coronavirus Infections / complications
-
Coronavirus Infections / drug therapy*
-
Coronavirus Infections / epidemiology
-
Coronavirus Infections / virology
-
Genes, cdc / drug effects
-
Humans
-
Immunotherapy
-
Lung Neoplasms / complications
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / epidemiology
-
Lung Neoplasms / virology
-
Pandemics*
-
Pneumonia, Viral / complications
-
Pneumonia, Viral / drug therapy*
-
Pneumonia, Viral / epidemiology
-
Pneumonia, Viral / virology
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors
-
SARS-CoV-2
Substances
-
Antineoplastic Agents
-
B7-H1 Antigen
-
CD274 protein, human
-
CTLA-4 Antigen
-
CTLA4 protein, human
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor